GE Healthcare installs Discovery NM/CT 670 CZT in St. Louis hospital

GE Healthcare announced this week that its Discovery NM/CT 670 CZT has been installed at Barnes-Jewish Hospital in St. Louis, Mo., marking the first time one of these systems has been installed in North America.

The company says the ultra-high resolution SPECT/CT imaging system can reduce dose or scan time by up to 50 percent and called it “one of the biggest nuclear medicine technological breakthroughs since the introduction of the first general purpose gamma camera.”

“We are thrilled to be collaborating with Barnes-Jewish Hospital and Washington University to advance nuclear medicine,” Nathan Hermony, GE Healthcare general manager of nuclear medicine, said in a prepared statement. “We believe this new technology will significantly improve the way exams are performed today and enable new areas of exploration for researchers who are looking at ways to optimize imaging protocols and gain additional insights about patients’ condition.”

GE Healthcare says the Discovery NM/CT 670 CZT allows clinicians to both visualize and analyze multiple physiological processes in a patient using its hybrid SPECT/CT.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.